This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Delay in approving Provenge sparks protest in Washington
Ed Gorkes and other prostate cancer activists rallied in Washington to urge the FDA to approve Dendreon's Provenge vaccine despite a lack of final data. They cite advisory panel support and argue delay could cost thousands of lives, while critics warn data must prove effectiveness. The protest followed the FDA's request for more proof and highlighted concerns about race-based disparities in prostate cancer outcomes.
MENTIONED IN THIS ARTICLE
Philadelphia
Ed Gorkes
Horsham
Food and Drug Administration
Congress
FDA
Dendreon Corp
Washington, D.C
Andrew von Eschenbach
Gorkes
Provenge
Thomas Farrington
Prostate Health Education Network
Biotech
Dendreon
Mitchell H. Gold
University of Pennsylvania
Yvone Paterson
Advaxis Inc
Farrington
von Eschenbach